About the role
We are seeking an experienced Senior Scientist in In Vivo Pharmacology & Translational Research to join a fast-paced, high-growth biotechnology company. In this pivotal role, you will design, coordinate, and oversee preclinical in vivo studies through external CRO partners, playing a central role in establishing robust proof of concept across innovative oncology pipelines.
Key Responsibilities
- In Vivo Study Design & Execution: Independently design and plan robust preclinical in vivo studies (including efficacy, PK/PD, target engagement, mechanism of action, and tolerability) utilizing appropriate oncology models (CDX, PDX, and others). Ensure full compliance with relevant animal license and ethical standards.
- CRO Management & Oversight: Lead the scientific coordination and oversight of outsourced in vivo studies, including CRO selection, protocol development, study execution, troubleshooting, and rigorous quality control to ensure delivery of high-quality data on schedule.
- Data Analysis & Strategic Interpretation: Analyze and integrate complex in vivo efficacy, PK/PD, and pharmacodynamic biomarker data to evaluate compound performance, guide candidate optimization, and drive go/no-go decisions for pipeline progression.
- Translational Pharmacology: Develop and implement translationally relevant i...
About this listing
Screened by Joboru
This role passed our automated spam and quality filters and was active in our feed when last checked. Joboru is an aggregator — here is how we screen listings. If anything looks off, tell us.
Similar jobs you may like
Quality Control Laboratory Analyst
1 day agoOPR Ltd
Research Engineer - Connectivity & Smart Devices
1 day agoCentrica - CHP
Data Governance Analyst
1 day agoDGH Recruitment
Laboratory Technician
1 day agoIntertek
Development Technologist
1 day agoPremier Foods
Consultant Microbiologist
1 day agoNational Health Service
Biochemistry Clinical Scientist
1 day agoNational Health Service
Senior Applied Scientist
1 day agoMicrosoft
Global Banking & Markets, FICC Quantitative Researcher, Alpha monetization, VP, London
1 day agoGoldman Sachs